Artificial intelligence (AI)-based research to revolutionize the future of glaucoma treatment (IMAGE)

Chinese Medical Journals Publishing House Co., Ltd.

Artificial intelligence (AI)-based research to revolutionize the future of glaucoma treatment

Caption

The loss of retinal ganglion cells (RGCs) is a prevalent characteristic of glaucoma and often the reason behind disease progression. Now, a team of researchers has utilized AI to identify a RIPK3 inhibitor with neuroprotective properties. Findings can shape the future of glaucoma treatment.

Credit

Dr. Yuanxu Gao from Macau University of Science and Technology

Usage Restrictions

Credit must be given to the creator. Adaptations must be shared under the same terms.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.